baber/WOPTO huggingface dataset:
Patent NZ-332811-A (NZ)
Title: A topical pharmaceutical composition containing a sulphoquinovosy or sulphodeoxyhexosyl-diacyl glycerol
Inventor: VASANGE MERVI
IPC: A61K36/12
Filed: 1997-04-30
Abstract: The topical pharmaceutical composition comprises an SQDG (sulpholipid) of formula I R1O-CH2-CH(OR2)_CH2-O-A-SO3- wherein either: (i) A is deoxyhexose and R1 and R2 are independently H or optionally saturated, optionally hydroxy substituted acyl groups protonated or as a salt or (ii) A is quinovose and R1 and R2 are independently H, acetyl or acyl groups having from 14-22 carbons atoms and up to 6 unsaturations in combination with polyunsaturated fatty acid in the form of free fatty acids, monoacylglycerols, diacylglycerols or triacylglycerols and a therapeutically acceptable carrier. The topical composition is used to treat psoriasis or atopic dermatitis.
Patent NZ-501931-A (NZ)
Title: 13-dihydro-3' aziridino anthracyclines useful as an antitumor agent
Inventor: GERONI CRISTINA
IPC: A61K31/704
Filed: 1999-04-09
Abstract: An anthracycline glycoside of formula I, wherein the wavy line means that the hydroxy group at the 13-position may be at alpha or beta position, or a mixture thereof. Specific compounds include: 4-demethoxy-13 (S/R) dihydro-3'-deamino-3'-aziridinyl-4'-methansulfonyl daunorubicin, 4-demethoxy-13(S) dihydro-3'-deamino-3'-aziridinyl-4'-methansulfonyl daunorubicin, or 4-demethoxy-13(R) dihydro-3'-deamino-3'-aziridinyl-4'-methansulfonyl daunorubicin. A process for the preparation of an anthracycline glycoside of formula (I) the process comprising reducing the anthracycline of the formula II in presence of a reductive agent, such as sodium borohydride in a mixture of organic solvents, and, if desired and necessary, separating the resultant mixture of 13(R) and 13(S) compounds into the single diastereoisomer. Pharmaceutical compositions comprising anthracycline glycoside of formula I are useful in treating tumors such as leukaemia.
Patent NZ-504775-A (NZ)
Title: Simulated brick wall consisting of supports having upper and lower flanges with tiles simulating bricks located therebetween
Inventor: VARLEY DAVID
IPC: E04F13/08
Filed: 1998-11-26
Abstract: A method of hanging tiles comprises providing a surface to be clad with horizontally extending, elongate supports each having an upper flange (3) having a downwardly extending lip defining an open-bottomed groove (42). A lower flange has a series of tile retention pips (12) or a bead extending along its upper surface. The tiles have flanges (24) projecting upwardly from their upper edge, the flanges being spaced from the front surfaces of the tiles. The tiles further have ribs (26) extending horizontally along a lower region of their rear surfaces. The flanges (24) are offered up into the groove (42) during assembly and the ribs (26) retained behind the pips or beads (12) following assembly.
Patent NZ-507308-A (NZ)
Title: Materials and methods for gene therapy
Inventor: FLOTTE TERENCE R
IPC: C07K14/81
Filed: 1999-04-23
Abstract: Materials and methods for gene therapy pertaining to vectors which can be used to effect genetic therapy in animals or humans having genetic disorders where expression of high levels of a protein of interest are required to treat or correct the disorder.  The materials and methods of the invention can be used to provide therapeutically effective levels of a protein that is non-functional, or that is absent or deficient in the animal or human to be treated. In one embodiment, the materials and methods can be used to treat alpha-1-antitrypsin deficiency.
Patent NZ-508963-A (NZ)
Title: Method for preparing aloin by extraction
Inventor: COHEN AVRAHAM
IPC: C07H7/04
Filed: 1999-04-28
Abstract: A method for preparing aloin from a substance containing aloe by extraction and purification by crystallization.  The aloin is extracted from the yellow sap of aloe or from a derived product comprising a hard gum, in the presence of an aliphatic diol or triol of no more than 15 carbon atoms.
Patent NZ-509464-A (NZ)
Title: An electrochemical system comprising rigid support members having enclosures which are in flow communication with respective electrode members
Inventor: LACHANCE RAYNALD G
IPC: C25B9/00
Filed: 1998-01-02
Abstract: An electrochemical system comprising rigid support members having enclosures which are in flow communication with respective electrode members.  The cells are assembled as a contiguous stack of cells similar in appearance to a filter press.  Each cell includes an anode electrode with an anolyte chamber adjacent to the anode electrode, and a cathode electrode with a catholyte chamber adjacent to the cathode electrode.  The support members include a first and second rigid enclosure which have an inlet and outlet being in flow communication with the anolyte and catholyte chambers respectively.  The electrical connections between adjacent cells are made using double electrode plates 110.    In the illustrated embodiment, a mono-polar electrolyser uses double electrode plates where the planar double electrode plates connect cells in adjacent cell stacks.  The mono-polar characteristics of each cell are maintained by the presence of an air gap 28 isolating each adjacent stack of cells connected by each double electrode plate.
Patent NZ-510507-A (NZ)
Title: Conveying system for loading into a bin has a delivery end portion that has a width at least greater than half the width of distributor
Inventor: THORNBURROW JOHN MCLEAN
IPC: B65B25/04
Filed: 1999-08-25
Abstract: An article handling apparatus, particularly for fruit, includes a belt (11) which has its delivery end (12) substantially centrally positioned over a rotor (13) enabling the belt (11) to be relatively wide and capable of handling a substantial volume of fruit. Chutes (18) can feed fruit (3) on to wave action flaps (18a) enabling the fruit to be distributed front and back and each side of the delivery end (12).
Patent NZ-511987-A (NZ)
Title: Bale press for producing rectangular bales of harvested agricultural produce has a press chamber moveable between upper and lower conveyors which delimit the top and bottom of the press chamber
Inventor: SACHT HANS OTTO
IPC: A01F15/02
Filed: 1999-12-01
Abstract: The agricultural crop bailing press has an upper conveyor (13) defining the press chamber with the lower conveyor (14). The conveyors define the chamber with longitudinal and side walls (18-20).
Patent NZ-515780-A (NZ)
Title: Levodopa / carbidopa / entacapone pharmaceutical preparation
Inventor: KALLIOINEN SARI
IPC: A61P25/16
Filed: 2000-06-29
Abstract: An oral solid fixed dose composition comprising pharmacologically effective amounts of entacapone, levodopa, and carbidopa, or a pharmaceutically acceptable salt or hydrate thereof, and comprising at least one pharmaceutically acceptable excipient is disclosed. This composition can be used e.g. for the treatment of Parkinson's disease.
Patent NZ-517502-A (NZ)
Title: Parenteral cisplatin emulsion
Inventor: DAFTARY GAUTAM VINOD
IPC: A61K33/243
Filed: 2000-07-26
Abstract: A sterile pharmaceutical cisplatin composition as oil-in-water emulsions having low toxicity for parenteral administration wherein the cisplatin is incorporated into the oily phase.  The composition also contains an emulsifier, a chelating agent, a tonicity modifier and water.
Patent NZ-523394-A (NZ)
Title: Dairy protein processing and applications thereof
Inventor: BHASKAR GANUGAPATI VIJAYA
IPC: A23C9/142
Filed: 2002-12-24
Abstract: A method of manufacture of a substantially nugget-free cheese comprising: (a) dispersing in milk or water or other aqueous solutions a dried HY-MPC having at least 55% SNF as milk protein; (b) treating the resulting mixture with one or more coagulating enzymes to produce a curd; and (c) processing the curd to make cheese, wherein the dried HY-MPC is a MPC or MPI having whey proteins denatured to allow whey proteins to be incorporated into cheese in higher yield than the resulting yield when the corresponding MPC or MPI without denaturation of whey proteins is used and wherein the dried HY-MPC is a calcium depleted milk protein product and the extent of calcium depletion is sufficient to allow the manufacture of substantially nugget-free cheese.
Patent NZ-524735-A (NZ)
Title: Combination therapy for treatment of autoimmune diseases using B cell depleting/immunoregulatory antibody combination
Inventor: HANNA NABIL
IPC: A61K47/48
Filed: 2001-09-18
Abstract: Use of (a) an immunoregulatory antibody selected from an anti-CD80 (B7.1), anti-CD86 (B7.2), and anti-CD4 antibody, and (b) an antibody having a B cell depleting activity, for the manufacture of a medicament combination for simultaneous, separate or sequential use in treating an autoimmune disease in a mammal.
Patent NZ-525829-A (NZ)
Title: Improvement of graft acceptance by T cell ablation, areactivating the thymus and adminstrating hematopoietic or epithelial stem cells or progenitor cells
Inventor: BOYD RICHARD
IPC: A61K35/14
Filed: 2001-10-12
Abstract: A compound that disrupts sex steroid mediated signaling is used in the preparation of a medicament for enhancing the development of a chimeric thymus in a patient to improve the tolerance in the patient to a mismatched graft from a donor, wherein the patient has been or will be administered with cells that improve tolerance selected from dendritic cells, hematopoietic stem cells, hematopoietic progenitor cells, lymphoid cells, lymphoid stem cells, lymphoid progenitor cells, epithelial stem cells, genetically modified stem cells or myeloid progenitor cells. Preferably the compound is a LHRH analog.
Patent NZ-527336-A (NZ)
Title: Icosahedron dice with indicia corresponding to events of sports of card game, and game and rules using such a dice
Inventor: PATERSON JON H
IPC: A63F9/04
Filed: 2003-08-01
Abstract: The icosahedron dice has indicia on the faces with each face corresponding to actions, movements, events or positions of a particular sport or card game being simulated. The indicia selected upon throwing the dice represents an action, movement, event or position of the sports or card game being simulated in accordance with the rules of that particular sport or card game.
Patent NZ-529944-A (NZ)
Title: Active ingredient combination of (e.g. galanthamine or desoxypeganine with acamprosate or memantine) for treating narcotic or alcohol addiction
Inventor: MOORMANN JOACHIM
IPC: A61K31/485
Filed: 2002-06-15
Abstract: Disclosed herein is an active ingredient combination composed of at least one modulator of the cholinergic system with at least one substance having antiexcitatory activity for pharmacological addictive substance or intoxicant therapy, in particular the therapy of alcoholism, characterized in that the modulator or at least one of the modulators of the cholinergic system is an inhibitor of acetylcholinesterase which is preferably selected from the group comprising galanthamine and deoxypeganine and the pharmacologically acceptable salts and derivatives thereof. The substance having antiexcitatory activity or at least one of the substances having antiexcitatory activity may be selected from the group of NMDA receptor antagonists, preferably selected from the group which comprises acamprosate and memantine and the pharmacologically acceptable salts and derivatives thereof.
Patent NZ-530219-A (NZ)
Title: Use of a recombinant adenoviral vector of subgroup C for the in vitro delivery of a heterologous nucleic acid to a mesenchymal stem cell
Inventor: HAVENGA MENZO JANS EMCO
IPC: A61K35/28
Filed: 2002-07-05
Abstract: Use of a recombinant adenoviral vector of subgroup C for the in vitro delivery of a heterologous nucleic acid to a mesenchymal stem cell, wherein said recombinant adenoviral vector is provided with a tropism for mesenchymal stem cells, said adenoviral vector comprising a tropism determining part of a fiber protein derived from a subgroup B adenovirus, and wherein said subgroup B adenovirus is selected from the group consisting of adenovirus 11, -16, -35 and 51.
Patent NZ-531875-A (NZ)
Title: An enantiomerically pure diarylmethylpiperazine and methods for use in the treatment for conditions such as drug addiction, mental disorders, arthritis and asthma
Inventor: CHANG KWEN-JEN
IPC: A61P25/28
Filed: 2002-09-25
Abstract: A pure (-)3-((S)-((2S,5R)-4-allyl-2,5-dimethyl-1-piperazinly)(3-thienyl)methyl)phenol compound of formula (I) is disclosed. The use of the compound is described to be for the manufacture of a medicament for the treatment of disorders such as drug and alcohol addiction, mental illness, asthma and arthritis. A method for screening opioid respiratory depression-suppressing compounds is also described. This involves conducting in vitro activity reversal assays, of a candidate respiratory depression-suppressing compound in a receptor tissue, comparatively, in the absence and in the presence of an anti-suppression compound of the formula (I).
Patent NZ-536218-A (NZ)
Title: Floorboards for floorings
Inventor: PERVAN DARKO
IPC: E04F15/04
Filed: 2003-04-08
Abstract: Floorboards for making a floating floor have a core ( 30 ) which comprises at least two layers of material (L 1, L 2 ), which are arranged at different distances from the surface layer ( 31 ), and which differ in respect of material properties or material composition. Semi manufactures for making such floorboards are also disclosed.
Patent NZ-543195-A (NZ)
Title: Medical active agent patch optically less visible on skin
Inventor: BRACHT STEFAN
IPC: A61K9/70
Filed: 2004-04-08
Abstract: Provided is a process for the production of an active substance skin patch, said process comprising: a) producing patches of differing colours comprising dyes and pigments; b) comparing the patches to colour charts or skin areas of a first, a second or any other person having CIELAB lightness colour values L1 and L2 in the range from S° to 100°, c) measuring the colour values of the CIELAB lightness of the patches lon the .colour charts or on the skin of the persons and determining the difference between L2 and L1 in each particular case; d) selecting those patches with a colour value of the lightness L1 which is not less than 50% and not more than 200% of the lightness colour value L2. Further provided are patches produced by the process.
Patent NZ-543336-A (NZ)
Title: Surface immobilised multilayer structure of vesicles
Inventor: GRANELI ANNETTE
IPC: G01N33/543
Filed: 2004-04-07
Abstract: Provided is a biologically functional surface immobilised multilayer structure comprising a plurality of vesicles spaced apart from said surface, said vesicles comprising biologically active compounds providing the surface with its biological functionality wherein at least one layer of vesicles is directly attached to the structure by surface-immobilised linkers with vesicle-attached linkers, and wherein said linkers comprise oligonucleotides, and said binding of a linker to another linker is mediated through hybridisation of said oligonucleotides, wherein said vesicles are directly attached to the surface-immobilised linkers with vesicle-attached linkers, so that at least two vesicles are attached to each surface-immobilised linker and wherein each vesicle attached linker is adapted to bind to said surface-immobilised linkers but not to another vesicle-attached linker. Further provided are variations of the multilayer structures, including ones in which the multilayer structure can be released from the surface.
Patent NZ-546739-A (NZ)
Title: Bone plate
Inventor: BEUTTER FLORIAN
IPC: A61B17/00
Filed: 2003-10-30
Abstract: A bone plate (1), having an upper side (2), a bone-sided lower side (3), a first end (11), a second end (12) and several plate holes (4), arranged between both ends (11, 12) and connecting the upper side (2) to the lower side (3), the holes being provided for receiving bone screws. Two of the plate holes (4) are made of a combination of two partially overlapping drillings (5, 6) of different type. The first (5) of both drillings is a circular cylindrical drilling, having an internal thread (7) and a cylinder axis (9). The second drilling (6) has a cone axis (10) and tapers from the upper side (2) to the lower side (3) in the form of a frustum. The second drilling (6) is provided with an internal thread (8). The cylinder axis (9) is situated at a distance A from the cone axis (10), which is different from zero.
Patent NZ-563237-A (NZ)
Title: Effective use of dispersants in wallboard containing foam
Inventor: LIU QINGXIA
IPC: C04B38/00
Filed: 2006-06-13
Abstract: A method of utilizing foam and dispersant in a gypsum slurry comprising mixing stucco, a first dispersant and a first quantity of water to form a gypsum slurry, blending a soap, a second dispersant and a second quantity of water to make a foam, and combining the foam with the slurry.
Patent NZ-563911-A (NZ)
Title: Gelatin-containing topical composition
Inventor: DRAGET KURT INGAR
IPC: A61K47/36
Filed: 2006-05-19
Abstract: Disclosed is a topical pharmaceutical or cosmetic composition comprising a pharmaceutically or cosmetically active agent and a gelling agent, said gelling agent comprises a fish gelatin and a polysaccharide. The composition contains a continuous aqueous phase having a melting temperature in the range 20 to 42°C.
Patent NZ-575268-A (NZ)
Title: Post Harvest Treatment of Fruit
Inventor: GRECH NIGEL M
IPC: A23B7/157
Filed: 2009-03-03
Abstract: Disclosed is a composition comprising: a sorbic acid source selected from sorbic acid, an alkali metal salt of sorbic acid, or a combination thereof; and a phosphorous acid source selected from phosphorous acid, an alkali metal salt of phosphorous acid, or a combination thereof; wherein said composition is provided in a solid state or as a solution. Also disclosed is a method of protecting a fruit, a vegetable or an ornamental against post harvest microbial spoilage by applying the composition as stated in the specification.
Patent NZ-577031-A (NZ)
Title: Substituted pyrrole derivatives and their use as HMG-CO inhibitors
Inventor: SALMAN MOHAMMAD
IPC: C07D207/00
Filed: 2004-05-28
Abstract: Disclosed are substituted pyrrole compounds of formula Ib, their pharmaceutically acceptable salts, pharmaceutically acceptable solvates, tautomers, racemates, polymorphs, pure enantiomers, diastereoisomers, or N-oxides wherein the substituents are as defined in the specification and their use as 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors. (62) Divided Out of 543741
Patent NZ-585744-A (NZ)
Title: Method of defining stereoscopic depth using manipulation of virtual 3D cameras
Inventor: SHAFER ANTHONY
IPC: G06T15/00
Filed: 2010-05-27
Abstract: A method for a computer system is disclosed. The method comprises: (a) providing a pair of 3D filtering glasses to a user with a right lens and a left lens, the left lens and the right lens comprised of complimentary filters; (b) while the user wears the 3D filtering glasses, providing the user with a left-eye image of a scene to the user's left eye on a display device and a right-eye image of the scene to the user's right eye on the display device; (c) providing a first and second virtual camera control device, wherein the control device comprises a first set of controls that are visible to the left eye and the right eye of the user while the user wears the 3D filtering glasses or a second set of controls that are operable by the user without looking away from the display device; (d) while the user wears the 3D filtering glasses, receiving input settings associated with a first virtual camera and/or a second virtual camera from the user manipulating the first and second virtual camera control device; (e) determining a first plurality of virtual camera parameters associated with the first virtual camera in response to the input settings; (f) determining a second plurality of virtual camera parameters associated with the second virtual camera in response to the input settings; (g) rendering a revised left-eye image of the scene in response to the first plurality of virtual camera parameters; (h) rendering a revised right-eye image of the scene in response to the second plurality of virtual camera parameters; and (i) while the user wears the 3D filtering glasses, providing the user with the revised left eye image of the scene to the left eye and the revised right-eye image of the scene to the right eye of the user.
Patent NZ-590584-A (NZ)
Title: Arrangement for the production of blade using resin that is degassed prior to mixing with a hardener
Inventor: SCHIBSBYE KARSTEN
IPC: B29C70/48
Filed: 2011-01-18
Abstract: The arrangement for the production of a blade is disclosed. The arrangement comprises a fist container (1), a second container (2), a degas system (3) and a machine (5). The first container (1) contains a resin. The resin is provided from the first container (1) to the degas system (3) to reduce the amount of gas in the resin. The second container (2) contains a hardener. The machine (5) is connected with the degas system (3) so that the gas reduced resin is provided to the machine (5). The machine (5) is connected with an enclosed composite structure (8) of the blade. The mixture of hardener and gas reduced resin is originated by the machine (5) and is injected into the composite structure (8) to manufacture the blade. The arrangement further comprises a measurement equipment that measures the level of gas within the resin. The flow through the degas system (3) is controlled in dependency of the level of gas in the resin that is measured by the measurement equipment.
Patent NZ-591948-A (NZ)
Title: Hydrophilic silicone monomers, process for their preparation and thin films containing the same
Inventor: GUYER KENDALL LOUIS
IPC: C01B33/00
Filed: 2009-10-05
Abstract: Disclosed is a mono-functional silicone-containing monomer o the formula R3Si-O - [Si(R)(Z)O]a - [Si(R1)(R2)O]b -SiR3 or formula II wherein the substituents are as described within the specification. Further disclosed is a polymer comprising the reaction product of at least one monomer of formula II, a copolymer comprising the reaction product of least two monomers of formula II wherein at least one of said monomers has a different structure to at least one other monomer, and a copolymer comprising the reaction product of at least one monomer of formula II and at least one additional monomer. Also disclosed is a process for producing a silicone-containing monomer. Also disclosed is a silicone-hydrogel film comprising a polymer comprising the reaction product of at least one monomer of formula II, and a contact lens comprising said silicone-hydrogel film.